v3.26.1
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating activities    
Net Income (Loss) $ (2,224,628) $ (1,709,533)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 5,924 1,106
Equity-based compensation 213,044 33,534
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (261,821) 46,328
Accounts payable (4,556) 254,645
Accrued expenses and other (617,292) 192,206
Net cash used in operating activities (2,889,329) (1,181,714)
Financing activities    
Proceeds from issuance of equity securities, net 0 655,202
Payments on note payable 0 (109,636)
Net cash provided by financing activities 0 545,566
Net decrease in cash (2,889,329) (636,148)
Cash, cash equivalents, and restricted cash at beginning of period 10,709,937 2,434,528
Cash, cash equivalents, and restricted cash at end of period 7,820,608 1,798,380
Supplemental cash flow information    
Cash paid for interest 8,476 4,094
Accrued issuance costs for public offering $ 0 $ 429,032